Kuopio, Finland

Tomi Järvinen

This inventor holds 1 USPTO granted patent. Top assignee: Leiras Oy. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomi Järvinen. Retrieved from https://idiyas.com/inventor/tomi-jandaumlrvinen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomi Järvinen: Innovator in Pharmaceutical Chemistry

Introduction

Tomi Järvinen is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on methylenebisphosphonic acid derivatives. His research has implications for the development of new pharmaceutical preparations.

Latest Patents

Järvinen holds a patent for "Methylenebisphosphonic acid derivatives." This invention focuses on novel halogen substituted methylenebisphosphonic acid anhydrides, ester anhydrides, amide anhydrides, and ester amide anhydrides. The patent also details processes for the preparation of these novel compounds, as well as pharmaceutical preparations that incorporate them. He has 1 patent to his name.

Career Highlights

Tomi Järvinen is associated with Leiras Oy, a company known for its research and development in pharmaceuticals. His work at Leiras Oy has allowed him to explore innovative solutions in drug development and contribute to advancements in the industry.

Collaborations

Throughout his career, Järvinen has collaborated with esteemed colleagues such as Esko Pohjala and Heikki Nupponen. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Tomi Järvinen's contributions to pharmaceutical chemistry through his patent on methylenebisphosphonic acid derivatives highlight his role as an innovator in the field. His work continues to influence the development of new pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…